Fate Therapeutics Stock Forecast
Forcasts, revenue, earnings, analysts expectations, ratios for fate therapeutics, inc. 61 rows close price at the end of the last trading day (thursday, 2nd dec 2021) of the.
The fate therapeutics stock forecast is 107.33572398594 usd for 2022 november 23, wednesday;
Fate therapeutics stock forecast. The average fate therapeutics stock price prediction forecasts a potential downside of n/a from the current fate share price of $51.77. Today 200 day moving average is the resistance level ( 78.36 $). Fate therapeutics (fate) stock price prediction is 107.33572398594 usd.
Fate therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. During the last session, fate therapeutics inc. The average price target represents a 55.79% change from the last price of $71.53.
The minimum target price for fate therapeutics analysts is $ 105.63. (nasdaq:fate) stock analysts at piper sandler issued their q1 2023 eps estimates for shares of fate therapeutics in a report issued on thursday, november 4th. Annual revenue (last year) $31.4m:
Fate therapeutics's share price could stay at $106.63 by nov 9, 2022. Fate therapeutics inc stock forecast. (fate) stock quote, history, news and other vital information to help you with your stock trading and investing.
During the day the stock fluctuated 10.17% from a day low at $52.09 to a day high of $57.38. Negative dynamics for fate therapeutics shares will prevail with possible volatility of 3.034%. Its novel ex vivo cell programming approach applies to modulate the therapeutic function and direct the fate of immune cells.
Fate therapeutics inc stock forecast: Investorsobserver gives fate therapeutics (fate) an overall rank of 43, which is below average. Is estimated to report earnings on 11/04/2021.
Find the latest fate therapeutics, inc. Find the latest fate therapeutics, inc. Tenthoff forecasts that the biopharmaceutical.
What analysts cover fate therapeutics? And 417.623 usd for 2026 november 23, monday with technical analysis. Fate therapeutics has been rated by citigroup , roth capital , and svb leerink in the past 90 days.
The average price target is $111.44 with a high forecast of $145.00 and a low forecast of $80.00. Up to 53.14 usd fate stock price prognosis stock. Stock | fate | us31189p1021
Based on 11 wall street analysts offering 12 month price targets for fate therapeutics in the last 3 months. Forecast for fri 28 jan 2022 price 54.21 Stock forecasts (us) top 5 stock forecasts;
For fate therapeutics stock forecast 2022, 12 predictions are offered for each month of 2022 with average fate therapeutics stock forecast of $42.75, a high forecast of. On average, wall street analysts predict that. Fate therapeutics inc has risen higher in 4 of those 8 years over the subsequent 52 week period, corresponding to a historical accuracy of 50 %.
(nasdaq:fate)’s traded shares were 1.16 million, with the beta value of the company hitting 1.66. Over the next 52 weeks, fate therapeutics inc has on average historically risen by 70.9 % based on the past 8 years of stock performance. 50 day moving average is.
Fate therapeutics is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.
Post a Comment for "Fate Therapeutics Stock Forecast"